Skip to main
HCA
HCA logo

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Healthcare (HCA) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 29%
Buy 41%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

HCA Healthcare has demonstrated strong financial growth, as evidenced by a 3Q25 same-facility revenue increase of 9.2%, supported by a 2.4% rise in adjusted admissions. The company has reported notable positive trends in Medicare Advantage volumes and a solid payer mix, contributing to a 7.1% year-over-year increase in inpatient revenue per admission. Additionally, HCA's management has raised its 2025 adjusted EBITDA guidance to $15.25-15.65 billion, with core operational performance playing a significant role in this positive revision.

Bears say

HCA Healthcare's total debt to LTM EBITDA ratio is at 2.9x, indicating a slight improvement but still reflecting elevated leverage concerns within the business. The company is projecting a 5% headwind to its 2026 earnings estimate, combined with a contraction in its enterprise multiple to 8.75x, suggesting cautious sentiment regarding future profitability growth. Additionally, the anticipated growth rate of 3.9% for 2026 falls below HCA's long-term growth outlook, further highlighting the potential for financial struggles amid a challenging economic landscape.

HCA Healthcare (HCA) has been analyzed by 17 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 41% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HCA Healthcare (HCA) Forecast

Analysts have given HCA Healthcare (HCA) a Buy based on their latest research and market trends.

According to 17 analysts, HCA Healthcare (HCA) has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $473.47, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $473.47, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HCA Healthcare (HCA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.